プレミアアンチエイジング(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 化学 | 4934/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2025/04/04 | 日証協 | 452,308株 | -8.31% | 35,800株 | -43.71% | 585,626株 | -1.97% | 19,905株 | +12.53% |
2025/03/28 | 日証協 | 493,308株 | -1.73% | 63,600株 | -29.57% | 597,421株 | -4.12% | 17,689株 | -48.88% |
2025/03/21 | 日証協 | 501,997株 | -2.35% | 90,297株 | -45.68% | 623,121株 | -4.12% | 34,600株 | -35.21% |
2025/03/14 | 日証協 | 514,097株 | -3.62% | 166,236株 | +259.9% | 649,922株 | +0.76% | 53,400株 | +256% |
2025/03/07 | 日証協 | 533,397株 | -1.13% | 46,189株 | +3.82% | 645,022株 | -0.83% | 15,000株 | -19.74% |
2025/02/28 | 日証協 | 539,497株 | +5.37% | 44,489株 | +59.46% | 650,441株 | -1.29% | 18,689株 | -13.28% |
2025/02/21 | 日証協 | 512,008株 | +3.08% | 27,900株 | -53.34% | 658,941株 | -4.44% | 21,552株 | -55.15% |
2025/02/14 | 日証協 | 496,708株 | -7.37% | 59,800株 | -58.24% | 689,541株 | +3.03% | 48,052株 | -27.28% |
2025/02/07 | 日証協 | 536,219株 | +0.57% | 143,191株 | +177.46% | 669,289株 | +8.91% | 66,080株 | +5.56% |
2025/01/31 | 日証協 | 533,189株 | -4.88% | 51,608株 | -2.22% | 614,521株 | -4.03% | 62,600株 | +200.96% |
2025/01/24 | 日証協 | 560,520株 | -5.06% | 52,781株 | -67.94% | 640,321株 | -0.08% | 20,800株 | -68.39% |
2025/01/17 | 日証協 | 590,389株 | +12.99% | 164,620株 | +86.84% | 640,821株 | +8.54% | 65,800株 | +110.18% |
2025/01/10 | 日証協 | 522,508株 | -1% | 88,108株 | +56.5% | 590,427株 | +3.02% | 31,306株 | +301.36% |
2024/12/30 | 日証協 | 527,808株 | +2.31% | 56,300株 | -60.86% | 573,127株 | +0.4% | 7,800株 | -78.15% |
2024/12/27 | 日証協 | 515,908株 | -3.72% | 143,839株 | -52.38% | 570,827株 | -3.81% | 35,706株 | -77.42% |
2024/12/20 | 日証協 | 535,821株 | +40.13% | 302,077株 | +488.84% | 593,415株 | +13.94% | 158,106株 | +217.48% |
2024/12/13 | 日証協 | 382,368株 | -1.83% | 51,300株 | +15.02% | 520,834株 | -1.23% | 49,800株 | +0.2% |
2024/12/06 | 日証協 | 389,499株 | -5.01% | 44,600株 | -49.98% | 527,334株 | +1.48% | 49,700株 | +66.44% |
2024/11/29 | 日証協 | 410,051株 | +3.07% | 89,168株 | -10.71% | 519,634株 | +0.64% | 29,860株 | -5.8% |
※株式分割は考慮していませんのでご注意ください。
Page Top